- About Us
- Advisory Board
- Editorial
- Contact Us
- Advertise
- Contact MJH LS
- Do Not Sell My Information
- Terms and Conditions
- Privacy
© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.
Latest Conference Articles
Understanding the Effects of Polyunsaturated Fatty Acids on Multiple Sclerosis: Ludwig Kappos, MD, FEAN, FAAN
April 24th 2022, 8:00pm
American Academy of Neurology Annual Meeting
The professor of neurology at the University of Basel discussed a recent study presented at AAN 2022 on whether levels of polyunsaturated fatty acids are associated with MS disease activity or progression. [WATCH TIME: 4 minutes]
Ofatumumab Shows Decreased Effect on Microglial Activation in Relapsing Multiple Sclerosis
April 24th 2022, 2:00pm
American Academy of Neurology Annual Meeting
Patients treated with ofatumumab (Kesimpta; Novartis) demonstrated significant decreases in absolute and percent CD19 counts at day 5 of treatment, which persisted through the 90-day period.
Reasons for Selecting Certain Outcome Measures in Aducanumab’s Drug Development: Sharon Cohen, MD, FRCPC
April 22nd 2022, 5:00pm
American Academy of Neurology Annual Meeting
The neurologist and assistant professor at the University of Toronto provided insight on the differences between outcome measures for Alzheimer disease and how they factored into a new item-level analysis of aducanumab (Aduhelm; Biogen). [WATCH TIME: 3 minutes]
Episode 62: Advanced Therapeutics in Parkinson and Movement Disorders
April 22nd 2022, 11:00am
Mind Moments™, a podcast from NeurologyLive®, brings you an exclusive interview with Yasar Torres-Yaghi, MD.
Building the Next Generation of Migraine Specialists: Rashmi B. Halker-Singh, MD, FAAN, and Paul Mathew, MD, DNBPAS, FAAN, FAHS
April 21st 2022, 1:00pm
American Academy of Neurology Annual Meeting
The chair and vice-chair of the Headache and Facial Pain Section of the American Academy of Neurology provided insight on projects they feel are needed to advance the care of patients with migraine-related disorders. [WATCH TIME: 4 minutes]
Weighing Cardiovascular Risk When Treating Narcolepsy
April 20th 2022, 9:00pm
American Academy of Neurology Annual Meeting
Rami H. Ben-Joseph, PhD, executive director, Jazz Pharmaceuticals, provided insight on the real-world CV-BOND study that evaluates the cardiovascular burden in patients with narcolepsy.
Details of Item-Level Analysis of Aducanumab at AAN 2022: Sharon Cohen, MD, FRCPC
April 20th 2022, 1:00pm
American Academy of Neurology Annual Meeting
The neurologist and assistant professor at the University of Toronto detailed findings from a new analysis that supports meaningful treatment effect with aducanumab in Alzheimer disease. [WATCH TIME: 6 minutes]
The New Bar Set for Therapies in Treatment-Resistant Epilepsy: Jacqueline A. French, MD
April 19th 2022, 7:00pm
American Academy of Neurology Annual Meeting
The codirector of Epilepsy Clinical Trials at NYU Langone spoke to the progress that’s been made in treating refractory epilepsy and her hopes for the future of drug development in this area of medicine. [WATCH TIME: 5 minutes]
Exploring Repurposed Therapeutics to Treat COVID-19: Jennifer Frontera, MD
April 19th 2022, 1:00pm
American Academy of Neurology Annual Meeting
The professor of neurology at NYU Langone Grossman School of Medicine discussed what high-potential repurposed medications could be an option to treat symptoms of COVID-19 and the realistic possibility of clinical trials. [WATCH TIME: 4 minutes]
Top Priorities Within the Migraine Field: Rashmi B. Halker-Singh, MD, FAAN, and Paul Mathew, MD, DNBPAS, FAAN, FAHS
April 18th 2022, 1:00pm
American Academy of Neurology Annual Meeting
The chair and vice-chair of the Headache and Facial Pain Section of the American Academy of Neurology discussed some of the key research needs for migraine care going forward. [WATCH TIME: 3 minutes]